(2022). 基于YTHDC2、IGF2BP2和HNRNPC的头颈部鳞状细胞癌N6-甲基腺苷风险模型构建及临床应用评估. Hua xi kou qiang yi xue za zhi, 40(6), 704-709. https://doi.org/10.7518/hxkq.2022.06.012
Chicago Style (17th ed.) Citation"基于YTHDC2、IGF2BP2和HNRNPC的头颈部鳞状细胞癌N6-甲基腺苷风险模型构建及临床应用评估." Hua Xi Kou Qiang Yi Xue Za Zhi 40, no. 6 (2022): 704-709. https://doi.org/10.7518/hxkq.2022.06.012.
MLA (9th ed.) Citation"基于YTHDC2、IGF2BP2和HNRNPC的头颈部鳞状细胞癌N6-甲基腺苷风险模型构建及临床应用评估." Hua Xi Kou Qiang Yi Xue Za Zhi, vol. 40, no. 6, 2022, pp. 704-709, https://doi.org/10.7518/hxkq.2022.06.012.
Warning: These citations may not always be 100% accurate.